During the past decade, Comprehensive Cardiovascular Medical Group conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 4 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 4 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Comprehensive Cardiovascular Medical Group" #1 sponsor was "Abbott Medical Devices" with 4 trials, followed by "Boston Scientific Corporation" with 3 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored, "GE Healthcare" with 1 trials sponsored and "Zoll Medical Corporation" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Comprehensive Cardiovascular Medical Group" #1 collaborator was "ABX CRO" with 1 trials as a collaborator, "AG Mednet Inc." with 1 trials as a collaborator, "Advanced Clinical, LLC" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "H2O Clinical LLC" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Comprehensive Cardiovascular Medical Group" are "Heart Failure" (7 trials), "Cardiac Arrhythmia" (1 trials), "Congestive Heart Failure" (1 trials) and "Myocardial Infarction" (1 trials). Many other conditions were trialed in "Comprehensive Cardiovascular Medical Group" in a lesser frequency.

Most popular intervention types in "Comprehensive Cardiovascular Medical Group" are "Device" (8 trials) and "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "ACUITY Spiral Left Ventricular Lead" (1 trials), "Arrhythmia Management System (AMS)" (1 trials), "CRT Patients" (1 trials), "CRT-D System" (1 trials) and "Device Programming of the Boston Scientific Cardiac Resynchronization Therapy Defibrillator (CRT-D)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Comprehensive Cardiovascular Medical Group" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Comprehensive Cardiovascular Medical Group". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Comprehensive Cardiovascular Medical Group, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Comprehensive Cardiovascular Medical Group, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".